Immunogenicity and Reactogenicity of an Inactivated Quadrivalent Influenza Vaccine Administered Intramuscularly to Children 6 to 35 Months of Age in 2012–2013: A Randomized, Double-Blind, Controlled, Multicenter, Multicountry, Clinical Trial

Safety and Immunogenicity of an Inactivated Quadrivalent Influenza Vaccine in Children 6 Months through 8 Years of Age

(2014) David P. Greenberg et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Candidate: A Phase III Randomized Controlled Trial in Children

(2013) Joanne M. Langley et al.   JOURNAL OF INFECTIOUS DISEASES

A Randomized Trial of Candidate Inactivated Quadrivalent Influenza Vaccine versus Trivalent Influenza Vaccines in Children Aged 3–17 Years

(2013) Joseph B. Domachowske et al.   JOURNAL OF INFECTIOUS DISEASES

Vaccine for Prevention of Mild and Moderate-to-Severe Influenza in Children

(2013) Varsha K. Jain et al.   NEW ENGLAND JOURNAL OF MEDICINE

Recommendations for Prevention and Control of Influenza in Children, 2013-2014

(2013)   PEDIATRICS

A randomized controlled study to evaluate the immunogenicity of a trivalent inactivated seasonal influenza vaccine at two dosages in children 6 to 35 months of age

(2013) Noris Pavia-Ruz et al.   Human Vaccines & Immunotherapeutics

Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine

(2012) Carrie Reed et al.   VACCINE

Immunogenicity and Safety of 2 Dose Levels of a Thimerosal-Free Trivalent Seasonal Influenza Vaccine in Children Aged 6–35 Months: A Randomized, Controlled Trial

(2012) Joanne M. Langley et al.   Journal of the Pediatric Infectious Diseases Society

Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis

(2011) Michael T Osterholm et al.   LANCET INFECTIOUS DISEASES

Oil-in-Water Emulsion Adjuvant with Influenza Vaccine in Young Children

(2011) Timo Vesikari et al.   NEW ENGLAND JOURNAL OF MEDICINE

Randomized Controlled Trial of Dose Response to Influenza Vaccine in Children Aged 6 to 23 Months

(2011) D. M. Skowronski et al.   PEDIATRICS

Trivalent and quadrivalent MF59®-adjuvanted influenza vaccine in young children: A dose- and schedule-finding study

(2011) Giovanni Della Cioppa et al.   VACCINE

A randomized clinical trial assessing immunogenicity and safety of a double dose of virosomal-adjuvanted influenza vaccine administered to unprimed children aged 6–35 months

(2010) Susanna Esposito et al.   VACCINE